Oxypurinol
 | |
| Names | |
|---|---|
| Preferred IUPAC name
1,2-Dihydropyrazolo[4,3-e]pyrimidine-4,6-dione | |
| Systematic IUPAC name
1H,2H,4H,5H,6H-pyrazolo[3,4-d]pyrimidine-4,6-dione | |
| Other names
1H,2H,5H-pyrazolo[3,4-d]pyrimidine-4,6-dione Alloxanthine | |
| Identifiers | |
| 2465-59-0 | |
| 3D model (Jmol) | Interactive image |
| 139956 | |
| ChEBI | CHEBI:28315 |
| ChEMBL | ChEMBL859  |
| ChemSpider | 4483 |
| ECHA InfoCard | 100.017.792 |
| EC Number | 219-570-9 |
| KEGG | C07599 |
| MeSH | Oxypurinol |
| PubChem | 4644 |
| UNII | G97OZE5068 |
| |
| |
| Properties | |
| C5H4N4O2 | |
| Molar mass | 152.11086 |
| Appearance | white crystals |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Oxypurinol is an inhibitor of xanthine oxidase. It is an active metabolite of allopurinol and it is cleared renally. In cases of renal disease, this metabolite will accumulate to toxic levels. By inhibiting xanthine oxidase, it reduces uric acid production. High serum uric acid levels may result in gout, kidney stones, and other medical conditions.
References
This article is issued from Wikipedia - version of the 3/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.